Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cardiovascular events and all‐cause mortality in patients with chronic obstructive pulmonary disease using olodaterol and other long‐acting beta2‐agonists
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-03-24
DOI
10.1002/pds.5432
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
- (2020) Stefan Andreas et al. International Journal of Chronic Obstructive Pulmonary Disease
- Using propensity scores to estimate effects of treatment initiation decisions: State of the science
- (2020) Michael Webster‐Clark et al. STATISTICS IN MEDICINE
- Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease
- (2019) Meng-Ting Wang et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- The Danish health care system and epidemiological research: from health care contacts to database records
- (2019) Morten Schmidt et al. Clinical Epidemiology
- Safety of tiotropium/olodaterol in chronic obstructive pulmonary disease: pooled analysis of three large, 52-week, randomized clinical trials
- (2018) Gary T. Ferguson et al. RESPIRATORY MEDICINE
- Determinants of exacerbation risk in patients with COPD in the TIOSPIR study
- (2017) Peter MA Calverley et al. International Journal of Chronic Obstructive Pulmonary Disease
- Comprehensive assessment of the safety of olodaterol 5 µg in the Respimat® device for maintenance treatment of COPD: comparison with the long-acting β2-agonist formoterol
- (2017) Andrea Koch et al. npj Primary Care Respiratory Medicine
- Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study
- (2016) Kasper Adelborg et al. BMJ Open
- Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
- (2016) Jens Sundbøll et al. BMJ Open
- One-Year Safety of Olodaterol Once Daily via Respimat® in Patients with GOLD 2–4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis
- (2015) Lorcan McGarvey et al. COPD-Journal of Chronic Obstructive Pulmonary Disease
- Atrial and Ventricular Arrhythmia-Associated Factors in Stable Patients with Chronic Obstructive Pulmonary Disease
- (2015) Yuji Kusunoki et al. RESPIRATION
- The Danish National Patient Registry: a review of content, data quality, and research potential
- (2015) Morten Schmidt et al. Clinical Epidemiology
- The Danish Civil Registration System as a tool in epidemiology
- (2014) Morten Schmidt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Tiotropium Handihaler and the risk of cardio- or cerebrovascular events and mortality in patients with COPD
- (2011) K.M.C. Verhamme et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Validity and underrecording of diagnosis of COPD in the Danish National Patient Registry
- (2011) Reimar W. Thomsen et al. RESPIRATORY MEDICINE
- A most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies
- (2009) Jaclyn L.F. Bosco et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Predictive values of acute coronary syndrome discharge diagnoses differed in the Danish National Patient Registry
- (2008) Albert Marni Joensen et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now